Trina Elementa Hybrid Genset Pairs Gas and Batteries for AI Sites

Containerized battery units and gas engine generators beside a data center at sunset
AI-generated illustration Data center developers have a timing problem. AI demand is arriving faster than grid connections, and waiting years for an interconnection is not an option for many projects. On November 19, 2026, Trina Storage unveiled a possible bridge: Elementa Hybrid Genset, a modular power plant that pairs gas generation with battery storage and a shared controller. The launch took place at RE+ 2026 in Las Vegas, and the details below come from Trina Storage's press release...
More

Drug prevents Type 1 diabetes in mice

A compound that blocks the synthesis of hyaluronan, a substance generally found in in all body tissue, protects mice from getting Type 1 diabetes.Nadine Nagy and Paul Bollyky and their colleagues found that a drug helped prevent the onset of Type 1 diabetes in mice. They hope to find out if the drug will work similarly in humans. Type 1 diabetes, formerly called juvenile diabetes, afflicts one in 300 people in the United States. A compound that blocks the synthesis of hyaluronan, a substance ...
More

Scientists Can Now 3D-Print The Building Blocks of Life

Scientists have developed a 3D-printing method capable of producing highly uniform blocks of embryonic stem cells. These cells are capable of generating all cell types in the body and could be used as the ‘Lego bricks’ to build tissue constructs, larger structures of tissues, and potentially even micro-organs. They could also be used for stem cell regulation and expansion, regenerative medicine, drug screening studies, and potentially even for the construction of micro-organs. “It was really ...
More

Antiviral compound fully protects monkeys from Ebola

Rhesus monkeys were completely protected from the deadly Ebola virus when treated three days after infection with a compound that blocks the virus's ability to replicate. These encouraging preclinical results suggest the compound, known as GS-5734, should be further developed as a potential treatment, according to research findings to be presented tomorrow at the IDWeek conference. Travis Warren, Ph.D., a principal investigator at the U.S. Army Medical Research Institute of Infectious Disease...
More